Q1 Revenue of $27.5 Million, Up 3.2% SequentiallyGross margin recovery and continued reduction in accounts receivableSequential improvement in Net loss and Return to Positive Adjusted EBITDAAdvancing Strategic Growth
LOS ANGELES, CA / ACCESS Newswire / November 4, 2026 / Ispire Technology Inc. (NASDAQ:ISPR) ("Ispire," the "Company," "we," "us," or "our"), a trailblazer in vaping technology and
Single platform connects verified users, authenticated products, configurable policy controls and compliance intelligence across the product life cycle, from manufacture through point of use LOS ANGELES, Sept. 28, 2026
LOS ANGELES, CA / ACCESS Newswire / September 9, 2026 / Ispire Technology Inc. (NASDAQ:ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and
Company Strengthens U.S.-Based Leadership and Investor CommunicationsLOS ANGELES, Aug. 17, 2026 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ: ISPR), today announced the
Partnership combines pharmaceutical-grade manufacturing with Ispire's global platform to accelerate entry into one of the fastest-growing nicotine segments LOS ANGELES, May 12, 2026 /PRNewswire/ -- Ispire Technology
Cash Increased Sequentially by $468,000 to $18 MillionPlans to Achieve Cash Flow Positive in Second Half of Calendar Year 2026 Business Stabilized Following Strategic RepositioningPhased Roadmap Targets Billions in
LOS ANGELES, May 1, 2026 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ:ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will host its
Companies outline public health case for point-of-use enforcement technologies and call for regulatory framework recognizing compliance software as a tobacco productLOS ANGELES, April 9, 2026 /PRNewswire/ -- IKE Tech LLC
FDA establishes first-ever framework for flavored ENDS, recognizing device level age verification as a regulatory requirementFDA guidance unlocks an estimated $50 billion total addressable market, allowing companies to
New FDA draft guidance formally acknowledges device-embedded age-gating technology in PMTA review for the first time, signalling the important role that technology and innovation can play in addressing youthusage and
Ongoing Focus on Collections Drives 19% Reduction in Net Accounts Receivable since June 30, 2025Cash of $17.6 Million at December 31, 2025
LOS ANGELES, Feb. 6, 2026 /PRNewswire/ -- Ispire Technology Inc.